Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study-Reference-Cited by-同舟云学术

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

Published:2022-02 Issue:2 Volume:20 Page:458-460.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Thomson Mary J.,Serper Marina,Khungar Vandana,Weiss L. Michael,Trinh Huy,Firpi-Morell Roberto,Roden Michael,Loomba Rohit,Barritt A. Sidney,Gazis Derek,Mospan Andrea R.,Fried Michael W.,Reddy K. Rajender,Lok Anna S.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. Statins for the primary prevention of cardiovascular disease;Taylor;Cochrane Database Syst Rev,2013

2. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial;Lewis;Hepatology,2007

3. Effects of hypercholesterolemia and statin exposure on survival in a large national cohort of patients with cirrhosis;Kaplan;Gastroenterology,2019

4. Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis;Kim;Clin Gastroenterol Hepatol,2017

5. Under-prescription of statins in patients with non-alcoholic fatty liver disease;Del Ben;Nutr Metab Cardiovasc Dis,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Lowering Medications for Managing Dyslipidemia: A Narrative Review;Cureus;2024-07-23

2. The Reply;The American Journal of Medicine;2024-07

3. Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology;Atherosclerosis;2024-05

4. A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-03

5. Increasing prevalence of cirrhosis among insured adults in the United States, 2012–2018;PLOS ONE;2024-02-26